Retinal vein occlusion (RVO) is a major cause of vision loss. The pathogenesis remains poorly defined although inflammation is known to play a critical role. In this study, we investigated the levels of comple... … [Read more...] about Intraocular complement activation is independent of systemic complement activation and is related to macular vascular remodelling in retinal vein occlusion
News
VIDEO: Transient monocular vision loss may signal impending stroke
November 24, 2024 2 min watch CHICAGO — In this Healio Video Perspective from the AAO meeting, Alexander S. Fein, MD, of Doheny Eye Institute and Stein Eye Institute at UCLA, discusses managing patients with transient monocular vision loss. According to Fein, transient monocular vision loss can be of a vascular origin and may be a sign of an impending stroke. “You need … [Read more...] about VIDEO: Transient monocular vision loss may signal impending stroke
NHS introduces OCT scans nationwide to improve diabetic eye care
A program from the National Health Service (NHS) England will bring optical coherence tomography (OCT) scans “closer to home” for thousands of patients. As part of an effort to improve outcomes for patients with diabetic retinopathy, OCT devices are rolling out in hospitals across the country, the NHS said in a news release. The NHS stated that around 4 million people are … [Read more...] about NHS introduces OCT scans nationwide to improve diabetic eye care
Ocular pain in Tibetan Plateau residents: Key findings on dry eye disease during COVID-19
A Chinese study1 led by co-authors Peng-Cheng Zhang, MD, PhD, and Wen-Shan Jiang , a PhD candidate, reported that ocular pain is a relatively common complaint in patients with dry eye disease (DED) living on the Tibetan plateau. The ocular pain was associated significantly with COVID-19 epidemic-induced anxiety, professional protection for the eyes, and adequate sleep are … [Read more...] about Ocular pain in Tibetan Plateau residents: Key findings on dry eye disease during COVID-19
VIDEO: Xipere demonstrates durability, safety in real-world setting
November 23, 2024 2 min watch In this Healio Video Perspective from the Retina Society meeting, Steven Yeh, MD, of Stanley M. Truhlsen Eye Institute, discusses Xipere for the treatment of noninfectious uveitis-associated macular edema. A study investigated nearly 800 eyes of 750 patients treated with Xipere (triamcinolone acetonide injectable suspension, Bausch + … [Read more...] about VIDEO: Xipere demonstrates durability, safety in real-world setting
CHMP issues positive opinion for the marketing authorization of FYB203, a biosimilar candidate to aflibercept
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion for the marketing authorization of FYB203, a biosimilar candidate to aflibercept.In the joint press release1 from Formycon AG and Klinge Biopharma GmbH, Dr Stefan Glombitza, CEO of Formycon AG, commented on this approval, saying, “We are excited about the … [Read more...] about CHMP issues positive opinion for the marketing authorization of FYB203, a biosimilar candidate to aflibercept
This Week in Ophthalmology: Week of November 18, 2024
Editor's note: The below transcript has been lightly edited for clarity.Hello, I’m David Hutton of Ophthalmology Times. Welcome to another episode of This Week in Ophthalmology, a program looking at some of the week’s top headlines.In the headlines this week, Astellas Pharma announced the FDA has issued a Complete Response Letter (CRL) for avacincaptad pegol intravitreal … [Read more...] about This Week in Ophthalmology: Week of November 18, 2024
NIH highlights 5 key elements of cortical visual impairment (CVI)
A press release from the NIH announced that its scientific team has defined elements of brain-based visual impairment in children. Cerebral or cortical visual impairment (CVI) “has emerged as a leading cause of vision impairment starting in childhood in the US and other industrialized nations,” according to the press release.The NIH reported that a panel of experts convened by … [Read more...] about NIH highlights 5 key elements of cortical visual impairment (CVI)
Harrow expands patient access to eyecare medications with price reductions and GoodRx partnership
Harrow has announced an initiative to expand access and affordability for its ophthalmic pharmaceutical products. This includes a program of targeted price reductions for several Harrow products and a strategic partnership with GoodRx.A component of Harrow’s Access and Affordability Program is reducing the prices of several widely used eyecare products as a method of addressing … [Read more...] about Harrow expands patient access to eyecare medications with price reductions and GoodRx partnership
VIDEO: Cequa shows dry eye improvements in previously treated patients
November 22, 2024 2 min watch CHICAGO — In this Healio Video Perspective from the AAO meeting, Brandon D. Ayres, MD, of Wills Eye Hospital discusses a study exploring the impact of Cequa on patients with dry eye disease who were previously treated with Restasis. The phase 4 study enrolled patients who were not fully satisfied with Restasis (cyclosporine ophthalmic … [Read more...] about VIDEO: Cequa shows dry eye improvements in previously treated patients